Experimental study reveals that Helicobacter pylori promotes cisplatin resistance in gastric cancer cells via circ_0046854, highlighting a potential pathway to overcome chemoresistance.
Helicobacter pylori (HP) is considered a major risk factor for gastric cancer (GC) and during this process, cytotoxin‑associated gene A (CagA) plays in essence. The study mainly focused on the molecular mechanism of circular RNA 0046854 (circ_0046854) in HP‐induced GC. Clinically, 56 cases of GC and normal tissues were collected, and the GC tissues were divided into HP‐negative GC tissues (HP − ) and 33 HP‐positive GC tissues (HP + ). Tissue expression of circ_0046854, microRNA (miR)‐511‐3p and colony‐stimulating factor 1 (CSF1) was tested. BGC‐823/Cisplatin (DDP) resistant strain was induced and cell growth and DDP resistance were detected after HP infection. In vivo experiments were performed using a mouse xenograft model. The relationship between circ_0046854, miR‐511‐3p and CSF1 was confirmed. GC tissues especially HP + cancer tissues expressed high circ_0046854 and CSF1 and low miR‐511‐3p. HP‐induced circ_0046854 expression in GC cells through CagA. Inhibition of circ_0046854 or miR‐511‐3p elevation inhibited the growth and DDP resistance in GC cells. Circ_0046854 acted as a sponge for miR‐511‐3p, which targeted CSF1. Restoring CSF1 could abolish the inhibitory effect of miR‐511‐3p overexpression on CagA + HP‐induced GC progression in vitro. Circ_0046854 silencing repressed tumor growth and aggrandized the inhibiting effects of DDP on tumorigenesis in vivo . Circ_0046854/miR‐511‐3p/CSF1 axis may be involved in the development of HP‐induced GC, thus providing new ideas for studying the mechanism of HP‐related gastric diseases.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: